200 related articles for article (PubMed ID: 26993796)
1. Treatment adequacy of anxiety disorders among young adults in Finland.
Kasteenpohja T; Marttunen M; Aalto-Setälä T; Perälä J; Saarni SI; Suvisaari J
BMC Psychiatry; 2016 Mar; 16():63. PubMed ID: 26993796
[TBL] [Abstract][Full Text] [Related]
2. Treatment received and treatment adequacy of depressive disorders among young adults in Finland.
Kasteenpohja T; Marttunen M; Aalto-Setälä T; Perälä J; Saarni SI; Suvisaari J
BMC Psychiatry; 2015 Mar; 15():47. PubMed ID: 25881327
[TBL] [Abstract][Full Text] [Related]
3. Treatment of anxiety disorders in the Finnish general population.
Sihvo S; Hämäläinen J; Kiviruusu O; Pirkola S; Isometsä E
J Affect Disord; 2006 Nov; 96(1-2):31-8. PubMed ID: 16797721
[TBL] [Abstract][Full Text] [Related]
4. Treatment adequacy of anxiety and depressive disorders: primary versus specialised care in Spain.
Fernández A; Haro JM; Codony M; Vilagut G; Martínez-Alonso M; Autonell J; Salvador-Carulla L; Ayuso-Mateos JL; Fullana MA; Alonso J
J Affect Disord; 2006 Nov; 96(1-2):9-20. PubMed ID: 16793140
[TBL] [Abstract][Full Text] [Related]
5. Azapirones for generalized anxiety disorder.
Chessick CA; Allen MH; Thase M; Batista Miralha da Cunha AB; Kapczinski FF; de Lima MS; dos Santos Souza JJ
Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006115. PubMed ID: 16856115
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults.
Machmutow K; Meister R; Jansen A; Kriston L; Watzke B; Härter MC; Liebherz S
Cochrane Database Syst Rev; 2019 May; 5(5):CD012855. PubMed ID: 31106850
[TBL] [Abstract][Full Text] [Related]
7. Adequacy of treatment received by primary care patients with anxiety disorders.
Weisberg RB; Beard C; Moitra E; Dyck I; Keller MB
Depress Anxiety; 2014 May; 31(5):443-50. PubMed ID: 24190762
[TBL] [Abstract][Full Text] [Related]
8. Generalised anxiety disorder: treatment options.
Sramek JJ; Zarotsky V; Cutler NR
Drugs; 2002; 62(11):1635-48. PubMed ID: 12109925
[TBL] [Abstract][Full Text] [Related]
9. Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises.
Purgato M; Gastaldon C; Papola D; van Ommeren M; Barbui C; Tol WA
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011849. PubMed ID: 29975811
[TBL] [Abstract][Full Text] [Related]
10. Psychological therapies for treatment-resistant depression in adults.
Ijaz S; Davies P; Williams CJ; Kessler D; Lewis G; Wiles N
Cochrane Database Syst Rev; 2018 May; 5(5):CD010558. PubMed ID: 29761488
[TBL] [Abstract][Full Text] [Related]
11. Generalised anxiety disorder in elderly patients : epidemiology, diagnosis and treatment options.
Flint AJ
Drugs Aging; 2005; 22(2):101-14. PubMed ID: 15733018
[TBL] [Abstract][Full Text] [Related]
12. [Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].
Pélissolo A; André C; Chignon JM; Dutoit D; Martin P; Richard-Berthe C; Tignol J
Encephale; 2002; 28(6 Pt 1):510-9. PubMed ID: 12506263
[TBL] [Abstract][Full Text] [Related]
13. Treatment of major depressive disorder in the Finnish general population.
Hämäläinen J; Isometsä E; Sihvo S; Kiviruusu O; Pirkola S; Lönnqvist J
Depress Anxiety; 2009; 26(11):1049-59. PubMed ID: 19123456
[TBL] [Abstract][Full Text] [Related]
14. A risk-benefit assessment of buspirone in the treatment of anxiety disorders.
Pecknold JC
Drug Saf; 1997 Feb; 16(2):118-32. PubMed ID: 9067123
[TBL] [Abstract][Full Text] [Related]
15. Treatment of generalized anxiety disorder.
Gorman JM
J Clin Psychiatry; 2002; 63 Suppl 8():17-23. PubMed ID: 12044104
[TBL] [Abstract][Full Text] [Related]
16. Generalized anxiety disorder in primary care: mental health services use and treatment adequacy.
Roberge P; Normand-Lauzière F; Raymond I; Luc M; Tanguay-Bernard MM; Duhoux A; Bocti C; Fournier L
BMC Fam Pract; 2015 Oct; 16():146. PubMed ID: 26492867
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and correlates of eating disorders among young adults in Finland.
Lähteenmäki S; Saarni S; Suokas J; Saarni S; Perälä J; Lönnqvist J; Suvisaari J
Nord J Psychiatry; 2014 Apr; 68(3):196-203. PubMed ID: 23750986
[TBL] [Abstract][Full Text] [Related]
18. Interaction of pharmacological and psychological treatments of anxiety.
Lader MH; Bond AJ
Br J Psychiatry Suppl; 1998; (34):42-8. PubMed ID: 9829016
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
[TBL] [Abstract][Full Text] [Related]
20. Outcome of depressive and anxiety disorders among young adults: Results from the Longitudinal Finnish Health 2011 Study.
Kasteenpohja T; Marttunen M; Aalto-Setälä T; Perälä J; Saarni SI; Suvisaari J
Nord J Psychiatry; 2018 Apr; 72(3):205-213. PubMed ID: 29276896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
